Biomarker studies in reversed Barrett's esophagus

American Journal of Gastroenterology

Volumn 94, Issue 10, 1999, Pages 2829-2833

  Garewal, Harinder ^a   Ramsey, Lois ^a   Sharma, Prateek ^a   Kraus, Kevin ^a   Sampliner, Richard ^a   Fass, Ronnie ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER; KI 67 ANTIGEN; ORNITHINE DECARBOXYLASE; PROTEIN P53;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER RISK; CLINICAL ARTICLE; ESOPHAGUS CARCINOMA; GENE MUTATION; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; PRIORITY JOURNAL; SQUAMOUS EPITHELIUM; TUMOR SUPPRESSOR GENE;

AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; BIOPSY; ELECTROCOAGULATION; EPITHELIUM; ESOPHAGEAL NEOPLASMS; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; MUTATION; OMEPRAZOLE; ORNITHINE DECARBOXYLASE; PROTON PUMPS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0032842451     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1999.1424_d.x     Document Type: Article

References (17)

1. Blot W.J., Devesa S.S., Fraumeni J.F. Jr. Continuing climb in rates of esophageal adenocarcinoma An update . JAMA. 270:1993;1320.
2. Porter AD, Pellegrini CA. Is there regression in Barrett's esophagus? In: Buchler MW, Frei E, Klaiber CH, et al., eds. Gastroesophageal reflux disease (GERD): Back to surgery? Prog Surg. Basel: Karger, 1997;23:110-4.
3. Malesci A., Savarino V., Zentilin P., et al. Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole. Gastrointest Endosc. 44:1996;700-705.
4. Sharma P., Sampliner R.E., Camargo L. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. Am J Gastroenterol. 92:1997;582-585.
5. Overholt B., Panjehpour M., Tefftellar E., et al. Photodynamic therapy for treatment of early adenocarcinoma in Barrett's esophagus. Gastrointest Endosc. 39:1993;73-76.
6. Overholt B.F., Panjehpour M. Photodynamic therapy in Barrett's esophagus Reduction of specialized mucosa, ablation of dysplasia and treatment of superficial esophageal cancer . Semin Surg Oncol. 11:1995;372-376.
7. Berenson M.M., Johnson T.D., Markowitz N.R., et al. Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium. Gastroenterology. 104:1993;1686-1691.
8. Sampliner R.E., Fennerty M.B., Garewal H.S. Reversal of Barrett's esophagus with acid suppression and multi-polar electrocoagulation results of a controlled trial . Gastrointest Endosc. 44:1996;532-535.
9. Salo J.A., Salminen J.T., Kiviluoto T.A., et al. Treatment of Barrett's esophagus by endoscopic laser ablation and antireflux surgery. Ann Surg. 227:1998;40-44.
10. Garewal H.S., Sloan D., Sampliner R.E., et al. Ornithine decarboxylase assay in colorectal mucosa Methodologic issues of importance to quality control . Int J Cancer. 52:1992;355-358.
11. Krishnadath K.K., Tilanus H.W., Blankenstein M.V., et al. Accumulation of p53 protein in normal, dysplastic and neoplastic Barrett's esophagus. J Pathol. 175:1995;175-180.
12. Younes M., Ertan A., Lechago L.V., et al. p53 Protein accumulation is a specific marker of malignant potential in Barrett's metaplasia. Dig Dis Sci. 42:1997;697-701.
13. Sharma P., Morales T.G., Bhattacharyya A., et al. Squamous islands in Barrett's esophagus What lies underneath? Am J Gastroenterol. 93:1997;332-335.
14. Pegg A.E., McCann P.P. Polyamine metabolism and function. Am J Physiol. 243:1982;C212-C221.
15. Verma A.K., Boutwell R.K. Inhibition of carcinogenesis by inhibitors of putrescine biosynthesis. McCann P.P., Pegg A.E., Sjoerdsma A. Inhibition of polyamine metabolism. 1987;249-258 Academic Press, Orlando.
16. Garewal H.S., Gerner E.W., Sampliner R.E., et al. Ornithine decarboxylase and polyamine levels in columnar upper gastrointestinal mucosa in patients with Barrett's esophagus. Cancer Res. 48:1988;3288-3291.
17. Garewal H.S., Sampliner R.E., Gerner E., et al. Ornithine decarboxylase activity in Barrett's esophagus A potential marker for dysplasia . Gastroenterology. 94:1988;819-821.